Physician profile
Stephanie A Verderame
NPI 1730856840
$15,400.84
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $361 · 2022: $987 · 2023: $1,388 · 2024: $575 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,988 · Food and Beverage: $3,146 · Travel and Lodging: $1,998 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,988.00 |
| Food and Beverage | $3,146.40 |
| Travel and Lodging | $1,997.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,920.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $7,883.68 | 2025 | Symbravo |
| Impel Pharmaceuticals LLC | $3,677.19 | 2025 | Trudhesa |
| Abbvie INC. | $1,008.37 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $596.93 | 2022 | |
| Pfizer INC. | $539.19 | 2023-2025 | |
| Lundbeck LLC | $526.23 | 2022-2025 | Vyepti |
| Impel Pharmaceuticals INC. | $423.50 | 2022-2023 | Trudhesa |
| Amgen INC. | $267.35 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $236.33 | 2021 | |
| Lilly USA, LLC | $109.18 | 2024-2025 | Emgality |
| Teva Pharmaceuticals USA, INC. | $34.52 | 2022-2023 | Austedo |
| Merck Sharp & Dohme LLC | $25.92 | 2023 | Belsomra |
| Idorsia Pharmaceuticals US INC | $21.69 | 2023 | Quviviq |
| Tonix Medicines, INC. | $20.68 | 2025 | Zembrace Symtouch |
| Scilex Pharmaceuticals INC. | $17.12 | 2023 | Ztlido |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amylyx Pharmaceuticals, INC. | $12.96 | 2023 | Relyvrio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Verderame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.